Catherine Sylvain

Catherine Sylvain is a Sr. Global Project Manager at Genentech, where they have been since 2019, leading critical manufacturing activities across US, China, and Europe to support clinical studies and regulatory submissions. Catherine brings a strong technical background, exceptional project management skills, and a collaborative approach to team-oriented projects. Previously, they held various roles in project management and medicinal chemistry at companies such as Rigel, FibroGen, and Proteolix, showcasing a breadth of experience in chemical development and project leadership. Catherine also pursued education at prestigious institutions including Stanford University and the University of California, Berkeley.